Real World Evidence: Time for a Switch?

Rachel E. Sobel, Andrew Bate () and Robert F. Reynolds
Additional contact information
Rachel E. Sobel: Pfizer Inc, Worldwide Safety and Regulatory
Andrew Bate: Pfizer Ltd, Worldwide Safety and Regulatory
Robert F. Reynolds: Pfizer Inc, Worldwide Safety and Regulatory

Drug Safety, 2018, vol. 41, issue 12, No 5, 1309-1312

Date: 2018
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40264-018-0739-y Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:drugsa:v:41:y:2018:i:12:d:10.1007_s40264-018-0739-y

Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/40264

DOI: 10.1007/s40264-018-0739-y

Access Statistics for this article

Drug Safety is currently edited by Nitin Joshi

More articles in Drug Safety from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().